SAN FRANCISCO, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Ackrell Capital today announced the publication of its "2018 Cannabis Investment Report." Ackrell Capital's 180-page report provides in-depth analysis and insight into the current and future state of the rapidly developing global cannabis industry.
The report provides a comprehensive view of the challenges and opportunities impacting a potential $500 billion global consumer market. The report looks at the state of global cannabis markets; analyzes capital markets for cannabis companies; examines the various segments within the cannabis industry; discusses legal issues pertinent to the cannabis industry; and presents updated market estimates and industry risks.
Key Features and Highlights of the Investment Report include:
Ackrell Capital publishes its report on the eve of a watershed event for the legalized cannabis industry – California’s implementation of its recreational cannabis law starting in January 2018. The world has yet to experience a legalized recreational cannabis market in a jurisdiction as large as California. Ackrell Capital estimates that California’s state-legal market will more than double from $3.2 billion in 2017 to approximately $6.5 billion in 2018.
Mike Ackrell, founder of Ackrell Capital, stated: “2018 will be an important year for the legalized cannabis industry, with California implementing its recreational cannabis law and Canada expected to pass a recreational law as early as July. There is significant global demand for legal access to cannabis, and public support has reached a tipping point in numerous states and countries. The steady march of cannabis legalization in the U.S. and around the world presents unique investment opportunities. Our 2018 Cannabis Investment Report provides sophisticated investors with a comprehensive view of the opportunities and risks in this rapidly developing market.”
Shannon Soqui, Head of Cannabis Investment Banking at Ackrell Capital, stated: “We believe that consumer cannabis use is about wellness, and we anticipate much more scientific knowledge about the potential medicinal benefits of cannabis to be forthcoming. Our report comes on the heels of a recent announcement by the World Health Organization that there is no evidence of any public health-related problems associated with the use of cannabidiol, or CBD. At least 20 countries now have medical laws that facilitate patient access to cannabis or concentrates for treating specified medical conditions, and we believe that the World Health Organization’s finding, and similar findings by others, will only accelerate legalization in the U.S. and globally. We are in the early stages of a global consumer industry that could see penetration levels similar to those for alcohol, tobacco and pharmaceuticals.”
To receive a complimentary copy of the "2018 Cannabis Investment Report," the "Top 100 Private Cannabis Companies 2018" and "The Green Field 2018," please visit: www.ackrell.com/cannabis.
About Ackrell Capital
Ackrell Capital is a leading independent investment bank focused on emerging growth companies. Ackrell Capital's expertise includes private equity, mergers and acquisitions advisory services, private placements of debt or equity, and corporate development services. Ackrell Capital’s sector focus includes cannabis, consumer, technology, digital and other emerging growth industries. Ackrell Capital was founded in 2003 and is based in San Francisco, CA. Ackrell Capital is a member of FINRA and SIPC. To learn more, please visit www.ackrell.com.
This press release and the "2018 Cannabis Investment Report," the "Top 100 Private Cannabis Companies 2018" and "The Green Field 2018" have been prepared for informational purposes only and are not and should not be construed as an offer to sell securities or a solicitation of an offer to buy securities. This press release contains forward-looking statements regarding future events or future performance. All statements other than present and historical facts and conditions are forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995, the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended). These statements reflect our current beliefs and expectations with respect to future events and are based on assumptions and subject to risk and uncertainties and subject to change at any time. You should not place undue reliance on these forward-looking statements. Actual events or results may differ materially from those contained in the forward-looking statements.
For media inquiries please contact:
Photos accompanying this announcement are available at: